Covid-19 and hepatic dysfunction- Severity of the disease

Santosh Kumar  Nayan; Santosh  Kumar; Abhay  Kumar; Anand  Dev; Siddharth  Singh

doi:10.51168/sjhrafrica.v5i12.1445

Authors

Santosh Kumar Nayan Associate Professor, Department of Trauma and Emergency, IGIMS, Patna, Bihar, India,
Santosh Kumar Assistant Professor, Department of Trauma and Emergency, IGIMS, Patna, Bihar, India,
Abhay Kumar Assistant Professor, Department of Trauma and Emergency, IGIMS, Patna, Bihar, India,
Anand Dev Assistant Professor, Department of Trauma and Emergency, IGIMS, Patna, Bihar, India,
Siddharth Singh Associate Professor, Department of Trauma and Emergency, IGIMS, Patna, Bihar, India

DOI:

https://doi.org/10.51168/sjhrafrica.v5i12.1445

Keywords:

COVID-19, liver dysfunction, association and severity

Abstract

Covid-19 and hepatic dysfunction- Severity of the disease

Author Biographies

Santosh Kumar, Assistant Professor, Department of Trauma and Emergency, IGIMS, Patna, Bihar, India,

Anand Dev, Assistant Professor, Department of Trauma and Emergency, IGIMS, Patna, Bihar, India,

References

Zhu NA , Zhang D , Wang W , Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382:727–33. doi:10.1056/NEJMoa2001017.

Gorbalenya AE , Baker SC , Baric RS , de Groot RJ, Drosten C, Gulyaeva AA, et al. Severe acute respiratory syndrome-related coronavirus: the species and its viruses–a statement of the coronavirus study group. Bio Rxivorg 2020;1-15. doi:10.1101/2020.02.07.937862.

WHO director-general’s opening remarks at the media briefing on COVID-19. Available at: https://www.who.int/dg/speeches/detail/who-director-general-s- opening-remarks-at-the-media-briefing-on-COVID-19—11-march-2020 Accessed on 1st August 2023.

WHO Coronavirus Disease. (COVID-19) dashboard. Available at https://COVID19.who.int/ Accessed on 1st August 2023

Aleem A, Shah H. Gastrointestinal and Hepatic Manifestations of Coronavirus (COVID-19) [Updated 2022 May 4]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK570562/

Chai X, Hu L, Zhang Y, Han W, Lu Z, Ke A, et al. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. bioRxiv 2020;1-13. doi:10.1101/2020.02.03.931766

Kumar-M P, Mishra S, Jha DK, Shukla J, Choudhury A, Mohindra R, et al.Coronavirus disease (COVID-19) and the liver: a comprehensive systematic review and meta-analysis. Hepatol Int 2020;14:711-22.

Huang C , Wang Y , Li X , Ren L, Zhao J, Hu Y,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497–506. doi: 10.1016/S0140-6736(20)30183-5.

Guan WJ , Ni ZY , Hu Y , Liang WH, Ou C, He J, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708–20. doi: 10.1056/NEJMoa2002032

Xu Z , Shi L , Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020;8:420–2. doi: 10.1016/S2213-2600 (20)30076-X

Cai Q , Huang D , Yu H , Zhu Z, Xia Z, Su Y, et al. COVID-19: abnormal liver function tests. J Hepatol 2020;73:566-574.doi: 10.1016/j.jhep.2020.04.006

Zhang C , Shi L , Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol2020;5:428–30. doi: 10.1016/S2468-1253 (20)30057-1

Ali N. Relationship between COVID-19 infection and liver injury: a review of recent data. Frontiers in medicine 2020;7:458.doi: 10.3389/fmed.2020.00458.

Zhu J, Ji P, Pang J, Zhong Z, Li H, He C, et al.Clinical characteristics of 3062 COVID-19 patients: A meta-analysis. J Med Virol 2020;92:1902-14. doi: 10.1002/jmv.25884.

Satapathy SK, Kuntzen C, Qiu H, Jiang Y, Bodenheimer HC, Roth NC, et al. Severity of liver test abnormalities in coronavirus disease 2019 depends on comorbidities and predicts early in-hospital mortality. Eur J Gastroenterol Hepatol 2021;33(1S Suppl 1):e320-e328. doi:10.1097/MEG.0000000000002055